BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23291960)

  • 1. Ubiquitin carboxy-terminal hydrolase L1 may be involved in the development of mammary phyllodes tumors.
    Lien HC; Wang CC; Huang CS; Yang YW; Kuo WH; Yao YT
    Virchows Arch; 2013 Feb; 462(2):155-61. PubMed ID: 23291960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IMP3 Is Strongly Expressed in Malignant Phyllodes Tumors of the Breast: An Immunohistochemical Study.
    Bellezza G; Prosperi E; Del Sordo R; Colella R; Rulli A; Sidoni A
    Int J Surg Pathol; 2016 Feb; 24(1):37-42. PubMed ID: 26353850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammary fibroadenoma and some phyllodes tumour stroma are composed of CD34+ fibroblasts and factor XIIIa+ dendrophages.
    Silverman JS; Tamsen A
    Histopathology; 1996 Nov; 29(5):411-9. PubMed ID: 8951485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of ubiquitin carboxy-terminal hydrolase L1 in breast carcinoma and its biological significance.
    Lien HC; Wang CC; Lin CH; Lu YS; Huang CS; Hsiao LP; Yao YT
    Hum Pathol; 2013 Sep; 44(9):1838-48. PubMed ID: 23664488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromal cells in phyllodes tumors of the breast are enriched for EZH2 and stem cell marker expression.
    Zhang Y; Liss AL; Chung E; Pierce LJ; Kleer CG
    Breast Cancer Res Treat; 2016 Jul; 158(1):21-28. PubMed ID: 27290698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of EMP1, EMP2, and EMP3 in breast phyllodes tumors.
    Cha YJ; Koo JS
    PLoS One; 2020; 15(8):e0238466. PubMed ID: 32857809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression-based classifications of fibroadenomas and phyllodes tumours of the breast.
    Vidal M; Peg V; Galván P; Tres A; Cortés J; Ramón y Cajal S; Rubio IT; Prat A
    Mol Oncol; 2015 Jun; 9(6):1081-90. PubMed ID: 25687451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptor-beta is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast.
    Sapino A; Bosco M; Cassoni P; Castellano I; Arisio R; Cserni G; Dei Tos AP; Fortunati N; Catalano MG; Bussolati G
    Mod Pathol; 2006 Apr; 19(4):599-606. PubMed ID: 16554735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ER, p53 and MIB-1 are significantly associated with malignant phyllodes tumor.
    Munawer NH; Md Zin R; Md Ali SA; Muhammad R; Ali J; Das S
    Biomed J; 2012; 35(6):486-92. PubMed ID: 23442362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phyllodes tumor: a clinicopathologic and immunohistochemical study of 30 cases.
    Esposito NN; Mohan D; Brufsky A; Lin Y; Kapali M; Dabbs DJ
    Arch Pathol Lab Med; 2006 Oct; 130(10):1516-21. PubMed ID: 17090194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant phyllodes tumours of the breast display increased stromal p53 protein expression.
    Millar EK; Beretov J; Marr P; Sarris M; Clarke RA; Kearsley JH; Lee CS
    Histopathology; 1999 Jun; 34(6):491-6. PubMed ID: 10383692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phyllodes Tumor of the Breast: Histopathologic Features, Differential Diagnosis, and Molecular/Genetic Updates.
    Zhang Y; Kleer CG
    Arch Pathol Lab Med; 2016 Jul; 140(7):665-71. PubMed ID: 27362571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased p53 protein expression in malignant mammary phyllodes tumors.
    Tse GM; Putti TC; Kung FY; Scolyer RA; Law BK; Lau TS; Lee CS
    Mod Pathol; 2002 Jul; 15(7):734-40. PubMed ID: 12118111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of c-kit in fibroepithelial lesions of the breast is a mast cell phenomenon.
    Djordjevic B; Hanna WM
    Mod Pathol; 2008 Oct; 21(10):1238-45. PubMed ID: 18500266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stromal matrix metalloproteinase-14 expression correlates with the grade and biological behavior of mammary phyllodes tumors.
    Kim GE; Kim JH; Lee KH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C; Park MH; Yoon JH
    Appl Immunohistochem Mol Morphol; 2012 May; 20(3):298-303. PubMed ID: 22505012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD10, actin, and vimentin expression in breast phyllodes tumors correlates with tumor grades of the WHO grading system.
    Tsai WC; Jin JS; Yu JC; Sheu LF
    Int J Surg Pathol; 2006 Apr; 14(2):127-31. PubMed ID: 16703173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phyllodes tumors and fibroadenoma common beginning and different ending.
    Oprić S; Oprić D; Gugić D; Granić M
    Coll Antropol; 2012 Mar; 36(1):235-41. PubMed ID: 22816226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-derived growth factor expression in phyllodes tumors and fibroadenomas of the breast.
    Feakins RM; Wells CA; Young KA; Sheaff MT
    Hum Pathol; 2000 Oct; 31(10):1214-22. PubMed ID: 11070114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of lymphoid enhancer-binding factor 1 in breast fibroepithelial lesions.
    Chen PH; Bossuyt V; Reisenbichler E
    Hum Pathol; 2021 Feb; 108():68-75. PubMed ID: 33245988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2005 Galloway Memorial Lecture: Breast phyllodes tumours--morphology and beyond.
    Tan PH
    Ann Acad Med Singap; 2005 Dec; 34(11):671-7. PubMed ID: 16453039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.